| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Epidemiologic classification of human papillomavirus types associated with cervical cancer.
|
N Engl J Med
|
2003
|
31.67
|
|
2
|
International network of cancer genome projects.
|
Nature
|
2010
|
20.35
|
|
3
|
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
|
Nature
|
2011
|
13.18
|
|
4
|
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.
|
J Infect Dis
|
2010
|
4.42
|
|
5
|
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.
|
J Natl Cancer Inst Monogr
|
2003
|
4.35
|
|
6
|
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
|
J Natl Cancer Inst
|
2006
|
4.14
|
|
7
|
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.
|
Int J Cancer
|
2006
|
3.38
|
|
8
|
Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
|
Int J Cancer
|
2012
|
3.35
|
|
9
|
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.
|
Vaccine
|
2006
|
2.95
|
|
10
|
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
|
Am J Epidemiol
|
2010
|
2.86
|
|
11
|
Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
|
Lancet Oncol
|
2011
|
2.52
|
|
12
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
|
13
|
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
|
Vaccine
|
2006
|
2.25
|
|
14
|
Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.
|
Int J Epidemiol
|
2008
|
2.00
|
|
15
|
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study.
|
Cancer Causes Control
|
2003
|
2.00
|
|
16
|
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
J Natl Cancer Inst
|
2012
|
1.99
|
|
17
|
The epidemiology of human papillomavirus infection and cervical cancer.
|
Dis Markers
|
2007
|
1.83
|
|
18
|
Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.77
|
|
19
|
Risk factors of invasive cervical cancer in Mali.
|
Int J Epidemiol
|
2002
|
1.74
|
|
20
|
Cost-effectiveness of HPV 16, 18 vaccination in Brazil.
|
Vaccine
|
2007
|
1.71
|
|
21
|
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.
|
Infect Agent Cancer
|
2012
|
1.69
|
|
22
|
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
|
Int J Cancer
|
2012
|
1.63
|
|
23
|
Human papillomavirus, human immunodeficiency virus and immunosuppression.
|
Vaccine
|
2012
|
1.58
|
|
24
|
NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma.
|
Leuk Res
|
2011
|
1.44
|
|
25
|
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
|
Int J Cancer
|
2014
|
1.40
|
|
26
|
Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies.
|
J Infect Dis
|
2012
|
1.38
|
|
27
|
Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.34
|
|
28
|
Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population.
|
J Clin Microbiol
|
2004
|
1.34
|
|
29
|
Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men.
|
Am J Epidemiol
|
2005
|
1.33
|
|
30
|
A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania.
|
Vaccine
|
2012
|
1.22
|
|
31
|
Human papillomavirus in cervical cancer.
|
Curr Oncol Rep
|
2002
|
1.19
|
|
32
|
Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.16
|
|
33
|
Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain.
|
BMC Infect Dis
|
2009
|
1.15
|
|
34
|
Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma--a multicentre European case-control study.
|
Int J Epidemiol
|
2008
|
1.15
|
|
35
|
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
|
Cancer Res
|
2008
|
1.13
|
|
36
|
Human Papillomavirus type distribution in invasive cervical cancer in Uganda.
|
BMC Infect Dis
|
2008
|
1.12
|
|
37
|
Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
|
Vaccine
|
2012
|
1.12
|
|
38
|
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy.
|
Vaccine
|
2012
|
1.06
|
|
39
|
Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
|
Int J Cancer
|
2008
|
1.05
|
|
40
|
Comprehensive control of human papillomavirus infections and related diseases.
|
Vaccine
|
2013
|
1.02
|
|
41
|
The clinical importance of understanding the evolution of papillomaviruses.
|
Trends Microbiol
|
2010
|
1.01
|
|
42
|
Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.
|
PLoS One
|
2012
|
1.01
|
|
43
|
Lymphoma risk and occupational exposure to pesticides: results of the Epilymph study.
|
Occup Environ Med
|
2012
|
1.01
|
|
44
|
Implementation of human papillomavirus immunization in the developing world.
|
Vaccine
|
2012
|
0.99
|
|
45
|
Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma.
|
Hum Mol Genet
|
2007
|
0.98
|
|
46
|
Biological convergence of cancer signatures.
|
PLoS One
|
2009
|
0.97
|
|
47
|
Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.96
|
|
48
|
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
|
Int J Cancer
|
2011
|
0.95
|
|
49
|
Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.
|
Infect Agent Cancer
|
2011
|
0.95
|
|
50
|
Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.94
|
|
51
|
Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults.
|
PLoS One
|
2012
|
0.94
|
|
52
|
Influence of familial cancer history on lymphoid neoplasms risk validated in the large European case-control study epilymph.
|
Eur J Cancer
|
2006
|
0.92
|
|
53
|
Reproductive factors and lymphoid neoplasms in Europe: findings from the EpiLymph case-control study.
|
Cancer Causes Control
|
2011
|
0.92
|
|
54
|
Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
|
Trop Med Int Health
|
2012
|
0.92
|
|
55
|
Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.
|
Rheumatology (Oxford)
|
2012
|
0.92
|
|
56
|
Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain.
|
J Low Genit Tract Dis
|
2008
|
0.91
|
|
57
|
Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
|
Br J Haematol
|
2011
|
0.90
|
|
58
|
Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
|
Int J Cancer
|
2014
|
0.89
|
|
59
|
Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
|
BMC Cancer
|
2010
|
0.89
|
|
60
|
Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma.
|
Int J Cancer
|
2006
|
0.89
|
|
61
|
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions.
|
Clin Vaccine Immunol
|
2007
|
0.88
|
|
62
|
Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature.
|
Am J Surg Pathol
|
2010
|
0.88
|
|
63
|
Comparison of 2 different PCR-based technologies for the detection of human papilloma virus from paraffin-embedded tissue: genómica clinical arrays versus SPF(10)-LiPA(25).
|
Diagn Mol Pathol
|
2012
|
0.87
|
|
64
|
High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects.
|
Sex Transm Infect
|
2013
|
0.87
|
|
65
|
Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002).
|
Eur J Cancer Prev
|
2010
|
0.86
|
|
66
|
A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.86
|
|
67
|
Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis.
|
Blood
|
2013
|
0.85
|
|
68
|
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
|
Cancer Causes Control
|
2012
|
0.85
|
|
69
|
Using HPV prevalence to predict cervical cancer incidence.
|
Int J Cancer
|
2012
|
0.85
|
|
70
|
Multiple myeloma and occupation: a pooled analysis by the International Multiple Myeloma Consortium.
|
Cancer Epidemiol
|
2013
|
0.84
|
|
71
|
Occupational exposure to meat and risk of lymphoma: a multicenter case-control study from Europe.
|
Int J Cancer
|
2007
|
0.84
|
|
72
|
Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
|
Gynecol Oncol
|
2011
|
0.84
|
|
73
|
[Screening history in women with infiltrating uterine cancer].
|
Gac Sanit
|
2006
|
0.83
|
|
74
|
Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
|
Eur J Public Health
|
2008
|
0.83
|
|
75
|
Occupational exposure to high molecular weight allergens and lymphoma risk among Italian adults.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.82
|
|
76
|
A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis.
|
Int J Cancer
|
2011
|
0.81
|
|
77
|
Human papillomavirus types in invasive cervical cancer specimens from Turkey.
|
Int J Gynecol Pathol
|
2009
|
0.81
|
|
78
|
Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
|
BMC Infect Dis
|
2012
|
0.80
|
|
79
|
Family clustering of blood cancers as a risk factor for lymphoid neoplasms.
|
Haematologica
|
2005
|
0.80
|
|
80
|
Appraisal of immune response in lymphoproliferative syndromes: a systematic review.
|
Crit Rev Oncol Hematol
|
2008
|
0.80
|
|
81
|
Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.
|
J Clin Microbiol
|
2013
|
0.80
|
|
82
|
Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.
|
Int J Cancer
|
2013
|
0.80
|
|
83
|
Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004.
|
Asian Pac J Cancer Prev
|
2010
|
0.79
|
|
84
|
Basaloid squamous cell carcinoma of the penis with papillary features: a clinicopathologic study of 12 cases.
|
Am J Surg Pathol
|
2012
|
0.79
|
|
85
|
Present and future of cervical cancer prevention in Spain: a cost-effectiveness analysis.
|
Eur J Cancer Prev
|
2016
|
0.78
|
|
86
|
[Assessment of HPV detection assays for use in cervical cancer screening programs].
|
Salud Publica Mex
|
2006
|
0.77
|
|
87
|
Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants.
|
J Clin Virol
|
2011
|
0.77
|
|
88
|
Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.
|
Menopause
|
2015
|
0.77
|
|
89
|
Antibody response to Merkel cell polyomavirus associated with incident lymphoma in the Epilymph case-control study in Spain.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.76
|
|
90
|
Occupational exposure to ethylene oxide and risk of lymphoma.
|
Epidemiology
|
2010
|
0.76
|
|
91
|
Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
|
PLoS One
|
2016
|
0.75
|
|
92
|
[Occupational risk of multiple myeloma: results from the EPILYMPH study].
|
G Ital Med Lav Ergon
|
2013
|
0.75
|
|
93
|
[Risk of multiple myeloma and agricultural exposures].
|
G Ital Med Lav Ergon
|
2013
|
0.75
|
|
94
|
Clinical management of abnormal cytology test results and costs associated with the prevention of cervical cancer in Spain.
|
J Low Genit Tract Dis
|
2010
|
0.75
|